110 results in Exploration of Neuroprotective Therapy
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Review
ADHD and alexithymia comorbidities impact on developmental language disordered and autistic youths: a dimensional treatment approach
Yvette Hus, Osnat Segal
Published: June 22, 2025 Explor Neuroprot Ther. 2025;5:1004110
This article belongs to the special issue Advances in the Pathogenesis, Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder
Open Access
Original Article
Higher mortality in stroke patients with active COVID-19 infection
Mostafa Almasi-Dooghaee ... Abdol-Hossein Vahabie
Published: June 22, 2025 Explor Neuroprot Ther. 2025;5:1004109
Open Access
Original Article
Passive immunization against amyloid peptide restores pattern separation deficits in early stage of amyloid pathology but not in normal aging
Karin Herbeaux ... Céline Héraud
Published: June 16, 2025 Explor Neuroprot Ther. 2025;5:1004108
Open Access
Review
Omega-3 fatty acids and fetal brain development: implications for maternal nutrition, mechanisms of cognitive function, and pediatric depression
Raghd M Ghazal, Moawiah M Naffaa
Published: May 28, 2025 Explor Neuroprot Ther. 2025;5:1004107
Open Access
Systematic Review
The effects of high-intensity training on walking speed and endurance in the subacute phase poststroke: a systematic review
Alejandro Ojeda-Manzano ... Alexandra Borstad
Published: May 22, 2025 Explor Neuroprot Ther. 2025;5:1004106
Open Access
Review
Neuroinflammation—the role of heteroreceptor complexes
Neelakanta Sarvashiva Kiran, Senthilkumar Rajagopal
Published: May 12, 2025 Explor Neuroprot Ther. 2025;5:1004105
This article belongs to the special issue GPCR Heteroreceptor Complexes as Key Players in Neuroprotection
Open Access
Review
Advancements in extracellular vesicle therapy for neurodegenerative diseases
Ningyun Hu ... Rong Ma
Published: May 06, 2025 Explor Neuroprot Ther. 2025;5:1004104
This article belongs to the special issue Breakthroughs in Mechanisms and Treatments for Neurodegenerative Diseases
Open Access
Perspective
ADHD from the perspective of the International Classification of Diseases (ICD-11) and the International Classification of Functioning, Disability and Health (ICF)
Michael Linden
Published: May 06, 2025 Explor Neuroprot Ther. 2025;5:1004103
This article belongs to the special issue Advances in the Pathogenesis, Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder
Open Access
Case Report
Multimodal physical therapy intervention based on a biobehavioral approach in a patient with chronic upper limb pain: a case report
Fernando-Balbino Blanco-Fernández ... Mónica Grande-Alonso
Published: April 26, 2025 Explor Neuroprot Ther. 2025;5:1004102
Open Access
Review
Therapeutic effect of erythropoietin and its derivatives in the treatment of acute ischemic stroke
Ramón Rama, Joan Ramon Torrella
Published: April 24, 2025 Explor Neuroprot Ther. 2025;5:1004101
This article belongs to the special issue Interdisciplinary Approach to Therapeutic Strategies of Neuroprotection in Present and Future
Open Access
Review
Role of dopamine receptor heteromerization in preclinical models of addiction and other psychiatric disorders
Adèle Vilette ... Peter Vanhoutte
Published: April 01, 2025 Explor Neuroprot Ther. 2025;5:1004100
This article belongs to the special issue GPCR Heteroreceptor Complexes as Key Players in Neuroprotection
Open Access
Original Article
Neurophysiological findings in Attention Deficit Hyperactivity Disorder, a Pandora’s box with therapeutic implications
Montserrat Gerez-Malo ... Carlos Acosta
Published: March 30, 2025 Explor Neuroprot Ther. 2025;5:100499
This article belongs to the special issue Advances in the Pathogenesis, Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder
Open Access
Review
Multilayered neuroprotection by cannabinoids in neurodegenerative diseases
Ahmed Hasbi, Susan R. George
Published: March 09, 2025 Explor Neuroprot Ther. 2025;5:100498
This article belongs to the special issue GPCR Heteroreceptor Complexes as Key Players in Neuroprotection
Open Access
Original Article
CE(20:4) and CE(22:5) cholesteryl ester levels are elevated in the plasma of Alzheimer’s disease patients with ε3/ε4 genotype
Eleonora Stefanini ... Rafael Franco
Published: February 24, 2025 Explor Neuroprot Ther. 2025;5:100497
Open Access
Original Article
The potential therapeutic effects of coenzyme Q10 on the sciatic nerve regeneration following short- and long-term injury
Ahmed Omer Mead ... Süleyman Kaplan
Published: January 26, 2025 Explor Neuroprot Ther. 2025;5:100496
Open Access
Mini Review
Therapeutic approaches for repeat expansion diseases: a comprehensive review
Afsana Bhuiyan
Published: December 25, 2024 Explor Neuroprot Ther. 2024;4:485–496
Open Access
Review
Exploring therapeutical targets and innovative treatments for ischemic stroke: a comprehensive review
Lidija Radenovic
Published: November 20, 2024 Explor Neuroprot Ther. 2024;4:459–484
This article belongs to the special issue Therapeutic Targets for Neuroprotection in Ischemic Stroke
Open Access
Review
Potentialities of IGF-1 for regulating oxidative stress in neuroinflammation and neurodegeneration: theoretical review
Macarena Lorena Herrera ... Claudia Beatriz Hereñú
Published: October 31, 2024 Explor Neuroprot Ther. 2024;4:442–458
Open Access
Review
Protein kinases as therapeutic targets for Alzheimer’s disease: a brief review
Isabela Marie Fernandes Silva ... Claudio Viegas Jr.
Published: October 28, 2024 Explor Neuroprot Ther. 2024;4:411–441
Open Access
Mini Review
Impaired glymphatic clearance is an important cause of Alzheimer’s disease
Iyawnna Hazzard ... Forshing Lui
Published: October 24, 2024 Explor Neuroprot Ther. 2024;4:401–410
This article belongs to the special issue The Urgent Need for New Hypotheses to Develop Effective Therapeutic Tools Against Alzheimer's Disease
Journal Information